Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 318,232 | 403,828 | 503,191 | 679,402 | 835,346 | 2,739,999 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | 318,232 | 403,828 | 503,191 | 679,402 | 835,346 | 2,739,999 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | 33,804 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 2,706,195 | |||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 318,232 | 403,828 | 503,191 | 679,402 | 835,346 | 2,739,999 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 5 | 11 | 3 | 12 | 44 | 75 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 23,497 | 3,865 | 2,500 | 39,873 | 69,735 | |
| 11 | Total support. Add lines 7 through 10 | 2,809,809 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2016 | (b) 2017 | (c) 2018 | (d) 2019 | (e) 2020 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2020 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2020 |
(iii) Distributable Amount for 2020 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2020 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2019 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2020: | ||||
| a From 2015....... | ||||
| b From 2016....... | ||||
| c From 2017....... | ||||
| d From 2018....... | ||||
| e From 2019....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2020 distributable amount | ||||
|
i
Carryover from 2015 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2020 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2020 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2020, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2020. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2021. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2016..... | ||||
| b Excess from 2017..... | ||||
| c Excess from 2018..... | ||||
| d Excess from 2019..... | ||||
| e Excess from 2020..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| PART II, LINE 10 | PRIOR YEAR EXPENSE ACCRUED NOT PAID 23,497 INSURANCE CLAIM RESTITUTION 3,865 RETROACTIVE DISCOUNT RECEIVED 2,500 FORGIVENESS OF PPP LOAN 39,333 OTHER INCOME 540 |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990 - ORGANIZATION'S MISSION | MISSION: TO FIGHT AGAINST COLORECTAL CANCER (CRC) BY SUPPORTING RESEARCH, LEADING ADVOCACY EFFORTS, AND FUNDING AWARENESS-BUILDING ACTIVITIES THAT PROMOTE EARLIER MESSAGING, ON-TIME SCREENING AND QUALITY OF LIFE-PRESERVING CARE AND TREATMENTS. |
| FORM 990 | ORGANIZATION'S MISSION MISSION: TO FIGHT AGAINST COLORECTAL CANCER (CRC) BY SUPPORTING RESEARCH, LEADING ADVOCACY, AND PROMOTING TREATMENT AND PREVENTION THROUGH EDUCATION AND AWARENESS. |
| FORM 990, PART III | DESCRIPTION OF FIRST EXEMPT PURPOSE ACCOMPLISHMENT SUPPORTING RESEARCH YOUNG INVESTIGATOR / EARLY CAREER AWARDS THE COLON CANCER FOUNDATION CONTINUES TO FULFILL ONE OF ITS CRITICAL MISSION OBJECTIVES - RECOGNIZING AND SUPPORTING EXCELLENCE IN TRANSLATIONAL RESEARCH FOCUSED ON THE MOLECULAR BIOLOGY OF COLORECTAL CANCER BY PROVIDING COLORECTAL CANCER RESEARCH SCHOLAR AWARDS FOR THE TOP-RANKING ABSTRACTS SUBMITTED BY TRAINEES OR JUNIOR FACULTY MEMBERS ATTENDING NATIONAL AND INTERNATIONAL CONFERENCES. AWARDS PROVIDE FUNDING TO COVER MEETING, REGISTRATION AND TRAVEL EXPENSES TO THE CONFERENCES. IN PROVIDING THESE AWARDS, THE FOUNDATION SEEKS TO BOTH SUPPORT AND PROMOTE COLORECTAL CANCER RESEARCH. THE FOUNDATION HAS A SPECIAL INTEREST IN THE BIOLOGY OF EARLY AGE ONSET AND HEREDITARY COLORECTAL CANCER. HOWEVER, RESEARCH INTO OTHER AREAS OF COLORECTAL CANCER (E.G., NOVEL TREATMENTS, INNOVATIVE MINIMALLY INVASIVE SCREENING TECHNOLOGIES) IS ALSO CONSIDERED. PARTICIPATING CONFERENCES AND ORGANIZATIONS CURRENTLY INCLUDE: THE COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED COLORECTAL CANCER (CGA-ICC); THE INTERNATIONAL SOCIETY FOR GASTROINTESTINAL HEREDITARY TUMORS (INSIGHT); AND THE SOCIETY FOR SURGICAL ONCOLOGY (SSO) AND, THE FOUNDATION'S OWN EARLY AGE ONSET COLORECTAL CANCER SUMMIT (EAO-CRC) TO FURTHER SUPPORT THOSE YOUNG OR EARLY CAREER INVESTIGATORS FOCUSING THEIR RESEARCH EFFORTS ON THE BIOLOGY OF EARLY AGE ONSET AND HEREDITARY COLORECTAL CANCER THE FOUNDATION INCORPORATED AN ABSTRACT/POSTER SESSION INTO ITS ANNUAL EARLY AGE ONSET COLORECTAL (EAO-CRC) CANCER SUMMIT. COLON CANCER PREVENTION INTERNSHIP PROGRAM THE COLON CANCER FOUNDATION (CCF) RECOGNIZES THE IMPORTANCE OF A NEW GENERATION OF PUBLIC HEALTH LEADERS WHO HAVE AN UNDERSTANDING OF PUBLIC HEALTH AND CANCER PREVENTION ISSUES AND THE ROLE OF INTERNATIONAL ORGANIZATIONS IN ACHIEVING OUR MISSION OF A WORLD WITHOUT COLORECTAL CANCER. IN THIS REGARD, THE CCF CREATED AND LAUNCHED AN INTERNSHIP PROGRAM THAT AIMS TO TRAIN YOUNG AND ENERGETIC INDIVIDUALS ENTERING THE FIELD OF PUBLIC HEALTH ESPECIALLY THOSE INTERESTED IN CANCER PREVENTION. THUS FAR OUR INTERNS HAVE COME FROM LEADING MEDICAL SCHOOLS, PUBLIC HEALTH AND COMMUNICATIONS PROGRAMS FROM AROUND THE COUNTRY AND EVEN THE GLOBE. DURING THE PROGRAM INTERNS WILL REVIEW NEW COLORECTAL CANCER (CRC) RESEARCH STUDIES, ATTEND CRC VIRTUAL CONFERENCES AND UPDATE OUR DIGITAL PLATFORM AND WEB ARTICLES TO REFLECT THE LATEST RESEARCH ON CANCER PREVENTION, INCLUDING DIET, EXERCISE, AND OTHER HEALTH HABITS AS WELL AS AVOIDING DANGEROUS EXPOSURES. THEY WILL PROACTIVELY RESEARCH CURRENT PUBLIC HEALTH ISSUES IN THE CRC PREVENTION SPACE, SUCCINCTLY ARTICULATE HEALTH RESEARCH AND POLICY TO A VARIETY OF AUDIENCES AND CRITICALLY ASSESS DIFFERING PERSPECTIVES ON HEALTH ISSUES - ALL REFLECTIVE OF A PATIENT'S JOURNEY THROUGH THE CONTINUUM OF CARE. THROUGH THESE INTERNSHIP OPPORTUNITIES, THEY WILL LEARN FIRST-HAND ABOUT PUBLIC HEALTH AND CANCER PREVENTION GAINING HANDS-ON EXPERIENCE IN SEVERAL POSSIBLE AREAS, INCLUDING COMMUNICATIONS/MEDIA RELATIONS, AND CONSTITUENT ENGAGEMENT. OUR ENTIRE TEAM INCLUDING OUR SOCIAL MEDIA AND PR INTERNS WILL WORK CLOSELY WITH THE MEDIA TO GET OUR MESSAGE OUT TO THE PUBLIC. CONNECTING WITH POLICY MAKERS AND DECISION MAKERS ON A NATIONAL LEVEL TO CHANGE PUBLIC POLICY AND WORKING WITH INDEPENDENT RESEARCHERS FROM AROUND THE COUNTRY TO BRING FAIR, UNBIASED AND NON-CORPORATE-FUNDED INFORMATION TO THE PUBLIC ABOUT TIMELY ISSUES THAT MATTER TO CLINICIANS AND PATIENTS SUCH AS DIET AND EXERCISE, FAMILY HISTORY, GENETIC SYNDROMES, AND CRC OF UNKNOWN CAUSE. THE COLON CANCER FOUNDATION (CCF) DIGITAL COMMUNITY - CRC CONNECT, THE LEADING INTERACTIVE, VIRTUAL COMMUNITY OF CRC HEALTHCARE PROFESSIONALS, ADVOCATES AND RESEARCHERS. THE COLON CANCER FOUNDATION DOUBLED DOWN ON ITS COMMITMENT TO FOSTER DIALOGUE BETWEEN CLINICIANS, RESEARCHERS, PATIENTS AND CAREGIVERS FOCUSED ON CRC. KNOWING THE VALUE THAT THE COLORECTAL CANCER COMMUNITY PUTS ON THE NETWORKING AND EDUCATIONAL OPPORTUNITY WE PROVIDE THROUGH THE EAO-CRC SUMMIT EACH YEAR WE INVESTED IN AND LAUNCHED CRCCONNECT.ORG - THE FIRST EVER ONLINE COMMUNITY BUILT TO FACILITATE 24/7 DIALOGUE BETWEEN CLINICIANS AND RESEARCHERS FOCUSED ON COLON CANCER, ESPECIALLY EAO-CRC. WE WERE THRILLED TO BUILD ON THAT VALUE AND ENTER INTO A NEW PHASE OF OUR WORK TOGETHER BY PROVIDING OUR COMMUNITY MEMBERS WITH A PHENOMENAL DIGITAL ENVIRONMENT TO CONNECT, ENGAGE AND SHARE CRITICAL CLINICAL AND RESEARCH INFORMATION AND BEST PRACTICES IN REAL-TIME. CRC CONNECT WILL HELP US COLLABORATE MORE DYNAMICALLY WITH OUR COMMUNITY MEMBERS, RECEIVE THEIR INPUT ON CRITICAL COLORECTAL CANCER ISSUES AND RESPOND MORE QUICKLY TO THESE EMERGING ISSUES IN A TIMELY MANNER. THIS WILL ONLY STRENGTHEN OUR ABILITY TO IMPLEMENT OUR MISSION OF A WORLD WITHOUT COLORECTAL CANCER AND OUR EAO-CRC SUMMIT FOCUSED OBJECTIVE OF "PUTTING KNOWLEDGE INTO ACTION." THROUGH THE VARIOUS COMMUNITIES AND WORKGROUPS, MEMBERS CAN GATHER TO CONTINUE DISCUSSIONS AND PROBLEM SOLVING STARTED AT THE EAO-CRC SUMMIT AND SHARE DOCUMENTS THAT WILL HELP TO ADVANCE OUR UNDERSTANDING OF "STATE OF THE SCIENCE", THE EARLY ONSET COLORECTAL CANCER INCIDENCE AND MORTALITY TRENDS, AND OUR STRATEGIC PRIORITIES. STRATEGIC PRIORITIES AND CONVERSATIONS: GAP 1: FAMILY HISTORY ASCERTAINMENT IN THE U.S. GAP 2: EARLIEST POSSIBLE DIAGNOSIS AND TREATMENT THROUGH TIMELY RECOGNITION OF THE SYMPTOMS AND SIGNS OF YOUNG ADULT CRC A. GAP 2A: EVIDENCE TO TRANSITION TO AGE 45 FOR AVERAGE-RISK SCREENING B. GAP 2B: ASSURING THOSE AT RISK FOR CRC PRIOR TO AGE 45 OR 50 ARE RISK STRATIFIED FOR EARLIER TESTING GAP 3: TIMELY, EFFECTIVE, QUALITY-OF-LIFE AND FERTILITY-PRESERVING STATE OF THE ART TREATMENT GAP 4: HOW DID THIS HAPPEN? INVESTIGATING THE CAUSES OF EAO-CRC GAP 5: NAVIGATING THE NEW POST-COVID-19 HEALTHCARE LANDSCAPE COLORECTAL CANCER PATIENT REGISTRY COLON AND RECTAL CANCER IS EMERGING AS ONE OF THE MOST COMMON CANCERS AROUND THE GLOBE. WE DO NOT YET KNOW THE CAUSE. DATA ON COLORECTAL CANCER IS VERY LIMITED AND YET CRITICAL TO BEING ABLE TO FIND THE ANSWERS. COMPREHENSIVE INFORMATION ON ALL ASPECTS OF COLORECTAL CANCER, INCLUDING DEMOGRAPHIC DETAILS, PATHOLOGY, AND TREATMENT OUTCOME ARE NEEDED AS THE MANAGEMENT OF COLORECTAL CANCER HAS EVOLVED RAPIDLY OVER THE YEARS INVOLVING SEVERAL DISCIPLINES INCLUDING GASTROENTEROLOGY, SURGERY, RADIOLOGY, PATHOLOGY, AND ONCOLOGY. AS A RESULT OF OUR COLLABORATION WITH BACKPACK HEALTH AND RESEARCHERS AROUND THE GLOBE, MEMBERS OF THE COLORECTAL CANCER PATIENT REGISTRY COMMUNITY WILL BECOME AN IMPORTANT SOURCE OF INFORMATION THAT CAN HELP THE DEVELOPMENT OF GUIDELINES TO IMPROVE COLORECTAL CANCER CARE, PARTICIPATE IN SURVEYS AND PLAY AN ACTIVE ROLE IN RESEARCH THAT WILL LEAD TO ANSWERS, NEW TREATMENTS, AND A BETTER LIFE FOR ALL THOSE AFFECTED BY THIS DEADLY DISEASE - AT ANY AGE. 00:00 | 02:09 THE THOMAS K. WEBER RESEARCH LIBRARY - IN MEMORY OF OUR FOUNDER, THE LATE DR. THOMAS K. WEBER, MD, FACS, THE FOUNDATION COMPILED AN EXHAUSTIVE E- LIBRARY OF HIS PUBLICATIONS. FIFTY MANUSCRIPTS THAT COVER THE MOLECULAR BIOLOGY, CLINICAL ADVANCES, AND EPIDEMIOLOGY OF COLORECTAL CANCER ARE INCLUDED WITHIN THE LIBRARY. THE RESEARCH TOPICS INCLUDE UNDERSTANDING THE MOLECULAR EVENTS THAT REGULATE COLONIC NEOPLASIA, ESTABLISHMENT OF A COLORECTAL CANCER REGISTRY, USING PET SCANS FOR COLORECTAL CANCER EVALUATION, FACTORS THAT REGULATE SURGICAL DECISIONS IN COLORECTAL CANCER METASTASES, INNOVATIVE TECHNIQUES IN COLORECTAL SURGERY, UNDERSTANDING THE EVOLUTION OF EARLY-AGE ONSET COLORECTAL CANCER, AMONG OTHER. THESE PAPERS ARE AVAILABLE FOR OUR COMMUNITY MEMBERS. EAO-CRC SUMMARY REPORT - CRITICAL FINDINGS - ABSTRACT ACCEPTED AT COLLABORATIVE GROUP OF THE AMERICAS (CGA) ANNUAL MEETING SINCE 2015, THE COLON CANCER FOUNDATION (CCF) HAS DRAWN ATTENTION TO THE RAPID RISE IN THE NUMBER OF YOUNG ADULTS (YAS) DIAGNOSED WITH COLORECTAL CANCER (CRC) BY INVITING EXPERT STAKEHOLDERS-HEALTH CARE PROVIDERS, EPIDEMIOLOGISTS, SCIENTISTS, POLICY RESEARCHERS, PATIENTS AND SURVIVORS-TO SHARE THEIR KNOWLEDGE AND EXPERIENCES AT THE EARLY-AGE ONSET COLORECTAL CANCER (EAO-CRC) SUMMIT. THE FIFTH ANNUAL EAO-CRC SUMMIT WAS HELD MAY 2-3, 2019, AND THIS REPORT PROVIDES AN OVERVIEW OF THE FINDINGS PRESENTED AT THE MEETING. THE REPORT GAVE A THOROUGH OVERVIEW OF THE SUMMIT IT'S FIVE MAIN SESSIONS AND THE FOLLOWING TOPICS: DEFINING THE EXTENT OF THE CRISIS, GLOBALLY AND IN THE U.S. FAMILY HISTORY ASCERTAINMENT IN THE U.S. (GAP 1) EARLIEST POSSIBLE DIAGNOSIS THROUGH TIMELY RECOGNITION OF SYMPTOMS AND SIGNS OF YOUNG ADULT CRC (GAP 2) TIMELY, EFFECTIVE QUALITY-OF-LIFE AND FERTILITY PRESERVING TREATMENT (GAP 3) INVESTIGATING THE CAUSES OF EAO-CRC (GAP 4) IN THE MONTHS FOLLOWING THE 2019 EAO-CRC SUMMIT, PROGRESS HAS BEEN MADE THAT ADDRESSES THE GAPS IDENTIFIED DURING THE SUMMIT. THE EARLY AGE ONSET COLORECTAL CANCER SUMMIT THE RATES OF THOSE DIAGNOSED WITH LATE STAGE CRC UNDER THE AGE OF 50 ARE STILL INCREASING AT DR |
| FORM 990, PAGE 2, PART III, LINE 4A | DESCRIPTION OF FIRST EXEMPT PURPOSE ACCOMPLISHMENT SUPPORTING RESEARCH 1.YOUNG INVESTIGATOR/EARLY CAREER AWARDS THE COLON CANCER FOUNDATION CONTINUES TO FULFILL ONE OF ITS CRITICAL OBJECTIVES - RECOGNIZING AND SUPPORTING EXCELLENCE IN TRANSLATIONAL RESEARCH FOCUSED ON THE MOLECULAR BIOLOGY OF COLORECTAL CANCER - BY PROVIDING COLORECTAL CANCER RESEARCH SCHOLAR AWARDS FOR THE TOP-RANKING ABSTRACTS SUBMITTED BY TRAINEES OR JUNIOR FACULTY MEMBERS ATTENDING PRESTIGIOUS NATIONAL AND INTERNATIONAL CONFERENCES. THESE AWARDS PROVIDE FUNDING TO COVER MEETING, REGISTRATION, AND TRAVEL EXPENSES. IN PROVIDING THESE AWARDS, THE FOUNDATION SEEKS TO BOTH SUPPORT AND PROMOTE COLORECTAL CANCER RESEARCH. THE FOUNDATION HAS A SPECIAL INTEREST IN THE BIOLOGY OF EARLY AGE ONSET AND HEREDITARY COLORECTAL CANCER. HOWEVER, RESEARCH INTO OTHER AREAS OF COLORECTAL CANCER (E.G. NOVEL TREATMENTS AND INNOVATIVE MINIMALLY INVASIVE SCREENING TECHNOLOGIES) IS ALSO CONSIDERED. PARTICIPATING CONFERENCES AND ORGANIZATIONS CURRENTLY INCLUDE THE FOLLOWING: -THE COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED COLORECTAL CANCER (CGA-ICC); -THE INTERNATIONAL SOCIETY FOR GASTROINTESTINAL HEREDITARY TUMORS (INSIGHT); AND -THE SOCIETY FOR SURGICAL ONCOLOGY (SSO). 2.THE EARLY AGE ONSET (EAO-CRC) COLORECTAL CANCER SUMMIT THE RATES OF THOSE DIAGNOSED WITH LATE STAGE CRC UNDER THE AGE OF 50 ARE STILL INCREASING DRAMATICALLY. THE FOUNDATION RECOGNIZED THIS TREND OVER A DECADE AGO AND HAS TAKEN THE LEAD ON ADDRESSING THE ISSUE BY ORGANIZING AND HOSTING THE NATION'S ONLY SUMMIT FOCUSED ON EAO-CRC. THE ANNUAL EAO-CRC SUMMIT IS A GROUNDBREAKING PROGRAM THAT PROVIDES SURVIVORS, LOVED ONES, HEALTH CARE PROFESSIONALS, AND RESEARCHERS FROM AROUND THE COUNTRY AND THE GLOBE THE UNIQUE OPPORTUNITY TO ADVANCE THEIR UNDERSTANDING OF THE RAPIDLY INCREASING INCIDENCE OF EAO-CRC WORLDWIDE IN A PATIENT/PROVIDER COLLABORATIVE SETTING. LEADING CLINICIANS AND SCIENTISTS REPORT ON THE EPIDEMIOLOGY, PATHOGENESIS, GENOMICS, AND LIFESTYLE CHALLENGES OF EAO-CRC. THE FOUNDATION TAKES PRIDE IN THE FACT THAT THE AGENDA OF THE FULL DAY PROGRAM IS INSPIRED BY THE EAO-CRC PATIENT COMMUNITY AND THEIR FAMILIES, AND GIVES THEM AN OPPORTUNITY TO BUILD CONNECTION AND COMMUNITY. FOR THE SECOND YEAR THE FOUNDATION OFFERED A CRITICAL COMPONENT TO THE SUMMIT - CME ACCREDITATION. HEALTH CARE PRACTITIONERS WERE ABLE TO CLAIM UP TO 11 AMA PRA CATEGORY 1 CREDITS. THE FOUNDATION WAS FORTUNATE TO PARTNER WITH THE NORTHWELL HEALTH OFFICE OF CONTINUING MEDICAL EDUCATION AND THE DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA/NORTHWELL FOR THE SECOND YEAR. ADDING CME ACCREDITATION ALLOWS US TO ATTRACT A WIDER AUDIENCE AND BROADEN THE IMPACT THE SUMMIT CAN HAVE ON HEALTH CARE PRACTITIONERS (HCPS). AND ONCE AGAIN THE ENTIRE EVENT WAS LIVE STREAMED AND VIDEOTAPED FOR FUTURE USE BY HEALTH CARE PROVIDERS, ACADEMICIANS, ETC. OUR ESTIMATED AUDIENCE REACH LEADING UP TO, DURING, AND IMMEDIATELY FOLLOWING THE EAO-CRC SUMMIT IS ESTIMATED AT APPROXIMATELY 4.7 MILLION UNIQUE VIEWERS. THE DIRECT RESULTS OF THIS CAN BE SEEN IN THE INCREASE OF ARTICLES, TELEVISION AND RADIO INTERVIEWS, AND RESEARCH PUBLICATIONS ON EAO-CRC. THE 2019 EAO-CRC SUMMIT THEME,PERFORMING A KNOWLEDGE GAP ANALYSIS AND BUILDING A STRATEGIC "ACTION PLAN" TO REDUCE EAO-CRC INCIDENCE AND MORTALITY, PROVIDED PARTICIPANTS THE OPPORTUNITY TO HEAR FROM AND QUESTION LEADING CLINICIANS AND RESEARCHERS ON THE LIFESAVING POTENTIAL OF TIMELY CLINICAL RISK ASSESSMENT/FAMILY CANCER HEALTH HISTORY; EARLIEST POSSIBLE DIAGNOSIS AND OPTIMAL FERTILITY-PRESERVING CLINICAL CARE; AS WELL AS THE LATEST INFORMATION REGARDING NATIONAL AND INTERNATIONAL EAO-CRC INCIDENCE TRENDS, PATHOGENESIS, AND GENETICS. IN ADDITION, THIS YEAR'S PROGRAM WILL PRESENT A "RESEARCH IN PROGRESS" SEGMENT FEATURING CURRENT NCI-FUNDED AND PLANNED EAO-CRC RESEARCH PROJECTS FROM ACROSS AMERICA AND EUROPE. AGAIN THIS YEAR, IMPORTANT BREAKOUT SESSIONS BASED ON NEEDS ASSESSMENTS FROM OUR SURVIVOR COMMUNITY WILL ADDRESS CHALLENGING ISSUES SURROUNDING PALLIATIVE CARE, SUPPORT NETWORKS FOR CAREGIVERS, AND A PRIMER ON THE EPIGENETICS OF EAO-CRC SPECIFICALLY REQUESTED BY OUR YOUNG ADULT CRC SURVIVOR PROGRAM ADVISORY GROUP. TO FURTHER SUPPORT THOSE YOUNG OR EARLY CAREER INVESTIGATORS, FOCUSING THEIR RESEARCH EFFORTS ON THE BIOLOGY OF EARLY AGE ONSET AND HEREDITARY COLORECTAL CANCER THE FOUNDATION INCORPORATED AN ABSTRACT/POSTER SESSION INTO ITS ANNUAL EARLY AGE ONSET COLORECTAL (EAO-CRC) CANCER (EAO-CRC) SUMMIT. ? FOR THE FIFTH YEAR THE FOUNDATION WAS ABLE TO ENGAGE A GLOBALLY RECOGNIZED FACULTY INCLUDING EAO-CRC SURVIVORS AS WELL AS CLINICIANS, EPIDEMIOLOGISTS, AND RESEARCHERS FROM LEADING CANCER CENTERS, ADVOCACY ORGANIZATIONS, AND RESEARCH INSTITUTIONS FROM AROUND THE US. OUR FACULTY REPRESENTED INSTITUTIONS AND ORGANIZATIONS INCLUDING THE FOLLOWING: ADCOUNCIL, ALIVEANDKICKN, AMERICAN CANCER SOCIETY, BOSTON UNIVERSITY SCHOOL OF MEDICINE, CANCER INSTITUTE AT NYU LANGONE, COLD SPRING HARBOR LABORATORIES, COLON CANCER COALITION, CHICAGO GASTRO LLC., COLORADO CENTER FOR PERSONALIZED MEDICINE, COLORECTAL CANCER ALLIANCE, DANA-FARBER CANCER INSTITUTE, EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC), FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH/NORTHWELL HEALTH, FUNDACION JIMENEZ DIAZ UNIVERSITY HOSPITAL, GASTROENTEROLOGY OF THE ROCKIES, GEISEL SCHOOL OF MEDICINE AT DARTMOUTH, HARVARD MEDICAL SCHOOL - BRIGHAM AND WOMEN'S HOSPITAL, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, MAINE DARTMOUTH FAMILY MEDICINE RESIDENCY, MD ANDERSON CANCER CENTER, MEMORIAL SLOAN KETTERING CANCER CENTER, MIDWEST GASTROENTEROLOGY ASSOCIATES, MONTEFIORE MEDICAL CENTER, NATIONAL COLORECTAL CANCER ROUNDTABLE, NEW YORK CITY DEPARTMENT OF HEALTH & MENTAL HYGIENE, NEW YORK PRESBYTERIAN/HERBERT IRVING COMPREHENSIVE CANCER CENTER, NORTHWELL HEALTH, NORTHWELL HEALTH CANCER INSTITUTE, OHIO STATE COMPREHENSIVE CANCER CENTER, PROVIDENCE CANCER INSTITUTE & PROVIDENCE ST. JOSEPH HEALTH, RANBAM HEALTH CARE CAMPUS, SOCIETY FOR HEALTH COMMUNICATION, SPECTRUM HEALTH MEDICAL GROUP, THE JACKSON LABORATORY FOR GENOMIC MEDICINE, THE UNIVERSITY OF CHICAGO MEDICINE COMER CHILDREN'S HOSPITAL, UNIVERSITY OF COLORADO ANSHUTZ MEDICAL CENTER, THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER, TULANE UNIVERSITY SCHOOL OF MEDICINE, UCSD SCHOOL OF MEDICINE, UNIVERSITY OF COLORADO SCHOOL OF MEDICINE, UNIVERSITY OF LOUISVILLE, UNIVERSITY OF MICHIGAN, UT SOUTHWESTERN MEDICAL CENTER, WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, AND YALE UNIVERSITY SCHOOL OF MEDICINE SMILOW CANCER CENTER. |
| FORM 990, PAGE 2, PART III, LINE 4B | DESCRIPTION OF SECOND EXEMPT PURPOSE ACCOMPLISHMENT 1.LEADING ADVOCACY EFFORTS THE COLON CANCER FOUNDATION IS AN ADVOCACY LEADER IN THE CRC LANDSCAPE THROUGH OUR COLLABORATIVE OUTREACH, PROGRAMMING, AND INTERNATIONAL NETWORK OF ACTION-TAKERS. WE HAVE A VISION OF A WORLD WITHOUT COLORECTAL CANCER, AND THAT IS WHY WE CONTINUOUSLY COLLABORATE WITH SCIENTISTS AT PUBLIC, PRIVATE, AND GOVERNMENT INSTITUTIONS TO OUTLINE THE RESEARCH PRIORITIES THAT WILL LEAD TO NEW DRUGS AND TREATMENT PROTOCOLS. THAT IS WHY WE ORGANIZE, HOST, AND FUND THE EAO-CRC SUMMIT AND EMPOWER ATTENDEES TO TAKE THEIR LEARNING BACK TO THEIR INSTITUTIONS, CITIES, AND COMMUNITIES IN ORDER TO MAKE CHANGE HAPPEN OUR NETWORK OF ACTION-TAKERS EXTENDS ACROSS THE COUNTRY AND THE GLOBE AND INCLUDES PATIENTS, CAREGIVERS, RESEARCHERS, AND HEALTH CARE PRACTITIONERS THAT REPRESENT EVERY ASPECT OF A PATIENT'S JOURNEY THROUGH THE CONTINUUM OF CARE - FROM BENCH TO BEDSIDE AND BEYOND. |
| FORM 990, PAGE 2, PART III, LINE 4C | DESCRIPTION OF 3RD EXEMPT PURPOSE ACCOMPLISHMENT 1.AWARENESS BUILDING ACTIVITIES THE FOUNDATION CONTINUED ITS MULTI-LEVEL PUBLIC AWARENESS AND EDUCATIONAL PROGRAM TO SPREAD THE CRITICAL MESSAGE THAT CRC IS A LARGELY PREVENTABLE DISEASE - IF CAUGHT EARLY. OUR SURROUND SOUND CAMPAIGN INCLUDES GRASSROOTS, ON THE GROUND EDUCATIONAL OUTREACH EVENTS, TELEVISION, RADIO, PRINT, AND DIGITAL ADVERTISING (PSA'S.) WE ALSO ATTEND OUTREACH EVENTS IN UNDERSERVED AND UNINSURED COMMUNITIES IN PARTNERSHIP WITH COMMUNITY HEALTH CENTERS AND SENIOR CENTERS. THROUGH ITS OUTREACH EVENTS AND ADVERTISING THE FOUNDATION REACHES AN ESTIMATED HALF A MILLION AMERICANS EACH YEAR. WHAT'S 20 FEET LONG 12 FEET HIGH, 10 FEET WIDE, INFLATABLE, EDUCATIONAL AND SHAPED LIKE A COLON? THE ROLLIN' COLON OF COURSE THANKS TO OUR SUPPORTERS, THE ROLLIN' COLON CONTINUED ITS NATIONAL TOUR IN 2019 CRISSCROSSING THE COUNTRY TO EDUCATE THOUSANDS ON COLORECTAL CANCER AND THE IMPORTANCE OF EARLY SCREENING. EDUCATIONAL MATERIALS ARE TRANSLATED INTO SPANISH AND CHINESE - ALLOWING THE FOUNDATION TO PROVIDE CULTURALLY RELEVANT EDUCATIONAL MATERIALS TO THE MANY UNDERSERVED AND UNDERINSURED COMMUNITIES WE VISIT. THE FOUNDATION'S LARGEST OUTREACH EVENT CONTINUES TO BE THE NEW YORK COLON CANCER CHALLENGE. THE FOUNDATION CELEBRATED THE 16TH ANNUAL NEW YORK COLON CANCER CHALLENGE ON RANDALL'S ISLAND IN NEW YORK CITY. THE CHALLENGE IS A UNIQUE OPPORTUNITY FOR SURVIVORS AND AFFECTED FAMILY MEMBERS TO HONOR LOVED ONES THEY MAY HAVE LOST OR TO CELEBRATE THEIR OWN VICTORY OVER COLORECTAL CANCER. HUNDREDS PARTICIPATED IN THE REMEMBRANCE AND PREVENTION WALK AND RUN. IN ADDITION, MEMBERS OF THE FOUNDATION'S COMMUNITY MAKE THEIR MILES COUNT IN THE FIGHT AGAINST CRC BY RUNNING EITHER THE UNITED AIRLINES NYC HALF MARATHON OR THE TCS NYC MARATHON. EACH MEMBER OF TEAM COLON CANCER CHALLENGE PLEDGES TO MAKE THEIR MILES COUNT BY RAISING AWARENESS OF THE NATION'S SECOND LEADING CANCER KILLER AND FUNDS TO SUPPORT OUR MISSION. 2.PARTNERSHIPS THE FOUNDATION IS PROUD OF OUR DIRECT GRASSROOTS OUTREACH TO COMMUNITIES AND INDIVIDUALS IN UNDERSERVED COMMUNITIES AND OUR WORK WITH LOCAL, REGIONAL, NATIONAL, AND INTERNATIONAL ORGANIZATIONS ON THE DEVELOPMENT AND IMPLEMENTATION OF UP TO DATE POLICIES AND PROGRAMS THAT CONTINUE TO ADDRESS CRC INCIDENCE AND DEATH AND QUALITY OF LIFE ISSUES AFFECTING PATIENTS AND CAREGIVERS. MEMBERS OF THE FOUNDATION'S LEADERSHIP TEAM SUPPORT, PARTICIPATE IN AND SERVE IN A LEADERSHIP CAPACITY ON MANY ORGANIZATIONS INCLUDING BUT NOT LIMITED TO THE FOLLOWING: -THE C5 SUMMIT (CITYWIDE COLON CANCER CONTROL COALITION), AN INITIATIVE OF THE NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE (NYCDOHMH); -THE COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED COLORECTAL CANCER (CGA); -THE GI CANCERS ALLIANCE (GICA); -THE INTERNATIONAL SOCIETY FOR GASTROINTESTINAL HEREDITARY TUMORS (INSIGHT); - NATIONAL COLORECTAL CANCER ROUNDTABLE (NCCRT); -THE NYS CANCER CONSORTIUM COLORECTAL CANCER ACTION TEAM; -THE SOCIETY FOR SURGICAL ONCOLOGY (SSO); AND -THE WESTCHESTER CANCER COALITION. |
| FORM 990, PART V | DESCRIPTION OF SECOND EXEMPT PURPOSE ACCOMPLISHMENT LEADING ADVOCACY EFFORTS THE FOUNDATION'S ADVOCACY EFFORTS IN 2020 DID NOT STOP JUST BECAUSE COVID- 19 WAS RAGING, IN FACT IT MADE OUR MESSAGE ALL THE MORE IMPORTANT. CANCER DOESN'T STOP FOR A PANDEMIC. AND, COVID-19 HAS HAD A DEVASTATING IMPACT ON SCREENING RATES. INITIAL DATA SUGGESTS THERE TO BE A 90% DROP IN COLONOSCOPIES AND BIOPSIES BY MID-APRIL OF 2020 COMPARED TO THE SAME PERIOD IN 2019. THERE WERE AN ESTIMATED 1.7M MISSED COLONOSCOPIES AND UNFORTUNATELY AN ESTIMATED 4,500+ EXCESS DEATHS WILL OCCUR FROM CRC OVER THE NEXT DECADE DUE TO THESE DELAYS. AS SOON AS IT WAS FEASIBLE, THE FOUNDATION JOINED EFFORTS WITH OTHER ORGANIZATIONS IN THE CRC SPACE ENCOURAGING THOSE AT GREATEST RISK FOR CRC TO GET SCREENED. IN ADDITION, THE FOUNDATION ADVOCATES FOR TIMELY, EFFECTIVE QUALITY-OF-LIFE AND FERTILITY-PRESERVING TREATMENT FOR ALL PATIENTS REGARDLESS OF WHERE THEY ARE TREATED. WHETHER IT BE AT LARGE ACADEMIC MEDICAL INSTITUTION IN A PROMINENT U.S. CITY OR A COMMUNITY CANCER CENTER. GAP 2 OF THE EAO-CRC SUMMIT FOCUSES LARGELY ON ADVOCATING FOR THIS CARE AS WELL AS EQUAL ATTENTION TO THE CAREGIVER THROUGHOUT THE PATIENT'S JOURNEY. |
| FORM 990, PART VI | DESCRIPTION OF 3RD EXEMPT PURPOSE ACCOMPLISHMENT PREVENTION & SCREENING THE FOUNDATION IS PROUD OF OUR DIRECT GRASSROOTS OUTREACH TO COMMUNITIES AND INDIVIDUALS IN UNDERSERVED COMMUNITIES AND OUR WORK WITH LOCAL, REGIONAL, NATIONAL AND INTERNATIONAL ORGANIZATIONS ON THE DEVELOPMENT AND IMPLEMENTATION OF UP TO DATE POLICIES AND PROGRAMS THAT CONTINUE TO ADDRESS COLORECTAL CANCER INCIDENCE AND DEATH AND QUALITY OF LIFE ISSUES AFFECTING PATIENTS AND CAREGIVERS. WE ARE ALSO PROUD OF OUR STRATEGIC ALLIANCES AND PARTNERSHIPS WITH MEDIA PARTNERS SUCH AS CANCER HEALTH, CURE, SMART AND STRONG AND URBAN HEALTH TODAY. WE ALSO PARTNER WITH ADVOCACY ORGANIZATIONS SUCH AS ALIVEANDKICKN, COLON TOWN, THE COLON CANCER COALITION, NEVER 2 YOUNG ALLIANCE, AND PATIENTS RISING. MEMBERS OF THE FOUNDATION'S LEADERSHIP TEAM SUPPORT, PARTICIPATE IN AND SERVE IN A LEADERSHIP CAPACITY ON MANY ORGANIZATIONS INCLUDING, BUT NOT LIMITED TO: -THE C5 SUMMIT (CITYWIDE COLON CANCER CONTROL COALITION), AN INITIATIVE OF THE NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE (NYCDOHMH); -THE GI CANCERS ALLIANCE (GICA); -THE INTERNATIONAL SOCIETY FOR GASTROINTESTINAL HEREDITARY TUMORS (INSIGHT); -MOUNT SINAI HOSPITAL CANCER EQUITY ACCELERATOR -THE NATIONAL COLORECTAL CANCER ROUNDTABLE (NCCRT) A NATIONAL COALITION OF PUBLIC ORGANIZATIONS, PRIVATE ORGANIZATIONS, VOLUNTARY ORGANIZATIONS, AND INVITED INDIVIDUALS DEDICATED TO REDUCING THE INCIDENCE OF AND MORTALITY FROM COLORECTAL CANCER IN THE U.S., THROUGH COORDINATED LEADERSHIP, STRATEGIC PLANNING, AND ADVOCACY. -THE NEW YORK CITY CANCER CONSORTIUM - THE NEW YORK STATE COLON CANCER CONSORTIUM, AND -THE WESTCHESTER CANCER COALITION. |
| FORM 990, PAGE 6, PART VI, LINE 11B | THE FORM 990 IS PRESENTED TO THE FOUNDATION'S FINANCE COMMITTEE FOR REVIEW. EDITS ARE INCORPORATED AND A FINAL COPY PRESENTED TO THE BOARD OF DIRECTORS FOR REVIEW PRIOR TO SUBMISSION. |
| FORM 990, PAGE 6, PART VI, LINE 12C | ON AN ANNUAL BASIS, BOARD MEMBERS COMPLETE AND SUBMIT A QUESTIONNAIRE TO THE BOARD CHAIR TO DISCLOSE WHETHER THERE ARE ANY CONFLICTS. THE BOARD AND THE EXECUTIVE DIRECTOR WILL EVALUATE CONFLICT DISCLOSURES AND MAKE OTHER NECESSARY INQUIRIES TO DETERMINE THE EXTENT AND NATURE OF ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST AND, IF APPROPRIATE, INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE POTENTIALLY CONFLICTING INTEREST AND ALL MATERIAL FACTS, AND AFTER ANSWERING ANY QUESTIONS, THE INTERESTED PERSON SHALL RECUSE HIMSELF OR HERSELF FROM DELIBERATIONS AND VOTING RELATING TO THE MATTER AND SHALL REFRAIN FROM ATTEMPTING TO INFLUENCE OTHER DECISION-MAKERS RELATING TO THE MATTER. HOWEVER, AS A MEMBER OF THE BOARD OR COMMITTEE, AN INTERESTED DIRECTOR MAY BE COUNTED IN DETERMINING THE ESTABLISHMENT OF THE QUORUM AT A MEETING RELATING TO THE MATTER. |
| FORM 990, PAGE 6, PART VI, LINE 15A | ON AN ANNUAL BASIS, THE FOUNDATION (EITHER THE FULL BOARD OR A COMPENSATION COMMITTEE/EXECUTIVE COMMITTEE) WILL EVALUATE THE EXECUTIVE DIRECTOR ON HIS/HER PERFORMANCE, AND ASK FOR HIS/HER INPUT ON MATTERS OF PERFORMANCE AND COMPENSATION. THE COMMITTEE WILL OBTAIN INDEPENDENT INFORMATION TO MAKE A RECOMMENDATION TO THE FULL BOARD FOR COMPENSATION (SALARY AND BENEFITS) OF THE EXECUTIVE DIRECTOR (AND OTHER HIGHLY COMPENSATED EMPLOYEES OR CONSULTANTS) BASED ON A REVIEW OF THE COMPARABLE DATA. THE DATA MAY INCLUDE THE FOLLOWING: 1. INFORMATION OBTAINED FROM THE IRS FORM 990 FILINGS OF SIMILAR ORGANIZATIONS; 2. SALARY AND BENEFIT COMPENSATION STUDIES BY INDEPENDENT SOURCES; AND/OR 3. WRITTEN JOB OFFERS FOR POSITIONS AT ORGANIZATIONS. TO APPROVE COMPENSATION OF THE EXECUTIVE DIRECTOR (AND OTHER HIGHLY COMPENSATED EMPLOYEES AND CONSULTANTS) THE BOARD MUST DOCUMENT HOW IT REACHED ITS DECISIONS, INCLUDING THE DATA ON WHICH IT RELIED, IN MINUTES OF THE MEETING DURING WHICH THE COMPENSATION WAS APPROVED. |
| FORM 990, PAGE 6, PART VI, LINE 17 | NEW HAMPSHIRE, NORTH DAKOTA, NEVADA, OHIO, OKLAHOMA, OREGON, RHODE ISLAND, SOUTH CAROLINA, UTAH, VIRGINIA, WASHINGTON, WEST VIRGINIA, WISCONSIN |
| FORM 990, PAGE 6, PART VI, LINE 18 | THE FOUNDATION'S FORM 990 IS ALSO AVAILABLE ON THE GUIDESTAR.ORG WEBSITE. |
| FORM 990, PAGE 6, PART VI, LINE 19 | FINANCIAL STATEMENTS ARE AVAILABLE ON THE ORGANIZATION'S WEBSITE. FORM 990 IS AVAILABLE ON THE GUIDESTAR.ORG WEBSITE. |
| Software ID: | |
| Software Version: |